Connect with us

Published

on

NCDC Diminish Fears Of Covid-19 Variant XEC In Nigeria—-XEC variant was observed for potential concerns, but it does not yet pose a significant risk

TCN reports that the Nigeria Centre for Disease Control and Prevention (NCDC) has reassured Nigerians that there is no cause for alarm following reports of the SARS-CoV-2 XEC variant, a sub-lineage of the Omicron strain, circulating in parts of the world, including Australia.

Director-General of NCDC, Dr Jide Idris, explained on Sunday that the XEC variant is classified as a Variant Under Monitoring (VUM). While the variant has been detected in 43 countries across Europe, Asia, North America, and recently in Africa (Botswana), it has yet to be identified in Nigeria.

He said the XEC variant was observed for potential concerns, but it does not yet pose a significant risk. He urged Nigerians to remain calm and continue adhering to basic preventive measures.

The JN.1 variant, a closely related Omicron sub-lineage, has been present in Nigeria since January 2024 and is also dominant globally. While the XEC variant demonstrates increased transmissibility, no evidence suggests it causes more severe illness.

Dr Jide reassured Nigerians that its COVID-19 Technical Working Group is closely monitoring the situation and analysing international and domestic data.

He advised Nigerians to stay informed through official channels and avoid spreading unverified information.

He also encouraged citizens to maintain personal hygiene, practice respiratory etiquette, use masks, get vaccinated and stay vigilant.

The DG urged healthcare workers to prioritise testing for respiratory and febrile illnesses and submit positive COVID-19 samples for genomic sequencing to aid monitoring efforts.

He also urged state governments to bolster health infrastructure, including diagnostic capabilities and public awareness campaigns, to enhance overall preparedness.

0Shares
Continue Reading
Click to comment

Leave a Reply

News

Virginia Representative Gerry Connolly Passes at 75 After Cancer Battle

Published

on

Gerry Connolly Passes at 75

Virginia Representative Gerry Connolly Passes at 75 After Cancer Battle—-Representative Gerry Connolly, a fiery Virginia Democrat with decades of experience on Capitol Hill, died Wednesday morning after a short stint with cancer, his family announced.

Connolly, 75, was a familiar figure around the halls of the Capitol, where he was known as a feisty advocate for the institutions of Washington — particularly following the Jan. 6, 2021, attack on the U.S. Capitol — and a champion of the many federal workers hailing from his Northern Virginia district.

First elected in 2008, Connolly rose this year to become the senior Democrat on the power House Oversight and Government Reform Committee — a seat he had sought unsuccessfully twice before.

His ascension was not without controversy. Connolly announced shortly after November’s elections that he was being treated for esophageal cancer, and a challenge for the ranking member seat from Rep. Alexandria Ocasio-Cortez (D-N.Y.) had rekindled the long-running generational debate over the role of seniority within the House Democratic Caucus.

Still, Connolly was a popular figure within the caucus, and he prevailed easily.

On Tuesday, Connolly joined forces with Rep. James Comer (R-Ky.), the chair of the Oversight Committee, to sponsor what would be his final piece of legislation: the Esophageal Cancer Awareness Act.

In a statement, Connolly’s family remembered him as a devoted family man and dedicated public servant, one who had served Northern Virginia for decades in both county and national politics.

“Gerry lived his life to give back to others and make our community better,” they wrote in a statement. “He looked out for the disadvantaged and voiceless. He always stood up for what is right and just.”

While pointing to Connolly’s accomplishments in elected office, the family said his greater contribution was to the local community, where he leaves behind a host of local projects that will serve as his legacy.

“[M]ore important than his accomplishments in elected office, Gerry lived by the ethos of ‘bloom where you are planted,’” they said. “From the Silver Line to the Oakton Library, Mosaic District to the Cross County Trail and beyond, his legacy now colors our region.”

Connolly’s illness had caused him to step back from his daily responsibilities on the Oversight Committee last month, when he tapped Rep. Stephen Lynch (D-Mass.), another senior member of the panel, to take the seat as interim ranking member — a temporary position requiring no elections.

With Connolly’s death, Democratic leaders will now start the process of seating a permanent replacement, which is likely to be fiercely contested and could pit senior members against a newer crop of up-and-coming Democrats clamoring to rise quickly in the ranks.

Lynch, 70, is among the most experienced Democrats on the panel, but several younger members — including Reps. Robert Garcia (D-Calif.) and Jasmine Crockett (D-Texas) — have expressed interest in the seat.

Ocasio-Cortez, for her part, has said she won’t seek the seat.

0Shares
Continue Reading

World

Former POTUS Joe Biden Diagnose With Advance Prostate Cancer

Published

on

Joe Biden Diagnose With Advance Prostate Cancer

Former POTUS Joe Biden Diagnose With Advance Prostate Cancer—-Former US President Joe Biden has been diagnosed with prostate cancer that has spread to his bones, a statement from his office said on Sunday.

Biden, 82, was diagnosed on Friday after he saw a doctor last week for urinary symptoms.

The cancer is a more aggressive form of the disease, characterised by a Gleason score of 9 out of 10. This means his illness is classified as “high-grade” and that the cancer cells could spread quickly, according to Cancer Research UK.

Biden and his family are said to be reviewing treatment options. The former president’s office added that the cancer is hormone-sensitive, meaning it can likely be managed.

After news broke of his diagnosis, the former president received support from both sides of the aisle.

President Donald Trump wrote on his social media platform Truth Social that he and First Lady Melania Trump “are saddened to hear about Joe Biden’s recent medical diagnosis.”

“We extend our warmest and best wishes to Jill and the family,” he said, referring to former First Lady Jill Biden. “We wish Joe a fast and successful recovery.”

Former Vice-President Kamala Harris, who served under Biden, wrote on X that she and her husband Doug Emhoff are keeping the Biden family in their prayers.

“Joe is a fighter — and I know he will face this challenge with the same strength, resilience, and optimism that have always defined his life and leadership,” Harris said.

The news comes nearly a year after the former president was forced to drop out of the 2024 US presidential election over concerns about his health and age. He is the oldest person to hold the office in US history.

Biden, then the Democratic nominee vying for re-election, faced mounting criticism of his poor performance in a June televised debate against Republican nominee and current president Donald Trump. He was replaced as the Democratic candidate by his vice president Harris.

Prostate cancer is the second most common cancer affecting men, behind skin cancer, according to the Cleveland Clinic. The US Centres for Disease Control and Prevention (CDC) says that 13 out of every 100 men will develop prostate cancer at some point in their lives.

Age is the most common risk factor, the CDC says.

Dr William Dahut, the Chief Scientific Officer at the American Cancer Society and a trained prostate cancer physician, told the BBC that the cancer is more aggressive in nature, based on the publicly-available information on Biden’s diagnosis.

“In general, if cancer has spread to the bones, we don’t think it is considered a curable cancer,” Dr Dahut said.

He noted, however, that most patients tend to respond well to initial treatment, “and people can live many years with the diagnosis”.

Dr Dahut said that someone with the former president’s diagnosis will likely be offered hormonal therapies to mitigate symptoms and to slow the growth of cancerous cells.

Biden had largely retreated from the public eye since leaving the White House and he has made few public appearances.

The former president delivered a keynote speech in April at a Chicago conference held by the Advocates, Counselors, and Representatives for the Disabled, a US-based advocacy group for people with disabilities.

In May, he sat down for an interview with the BBC – his first since leaving the White House – where he admitted that the decision to step down from the 2024 race was “difficult”.

Biden has faced questions about the status of his health in recent months.

In an appearance on The View programme that also took place in May, Biden denied claims that he had been experiencing cognitive decline in his final year at the White House. “There is nothing to sustain that,” he said.

For many years, the president had advocated for cancer research. In 2022, he and Mrs Biden relaunched the Cancer Moonshot initiative with the goal of mobilising research efforts to prevent more than four million cancer deaths by the year 2047.

Biden himself lost his eldest son, Beau, to brain cancer in 2015.

0Shares
Continue Reading

Trending

0Shares